Polycystic ovary syndrome - Searching for an animal model

Journal of Medicine

Volumn 29, Issue 5-6, 1998, Pages 259-275

  Szukiewicz, Dariusz ^a   Uilenbroek, Jan Th J ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Animal model; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; MIFEPRISTONE; PRASTERONE; TESTOSTERONE PROPIONATE;

ANDROGEN BLOOD LEVEL; ANIMAL MODEL; ARTICLE; ESTRADIOL BLOOD LEVEL; ESTRUS CYCLE; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION; RAT;

ANDROGENS; ANIMALS; CHORIONIC GONADOTROPIN; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; HUMANS; INSULIN; LIGHT; MIFEPRISTONE; POLYCYSTIC OVARY SYNDROME; RATS;

EID: 0032311198     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Adams, W.C., Sensemann, D.M. (1976). Aromatization of androstenedione by induced polycystic ovaries in the rat. J.Steroid.Biochem. 7: 309-310.
2. Anderson, E., Lee, G.Y. (1996). The effects of dehydroepiandrosterone (DHEA) and its metabolites on the polycystic ovarian condition (PCO): cystogenic changes of rat granulosa cells in vitro. Tissue Cell 28(6): 673-685.
3. Barnes, R.B., Rosenfield, R.L., Burstein, S., Ehrmann, D.A. (1989) Pituitary ovarian responses to nafarelin testing in polycystic ovary syndrome. N.Engl.J.Med. 350: 559-565.
4. Barraclough, C.A., Gorski, R.A. (1961). Evidence that the hypothalamus is responsible for androgen induced sterility in the female rat. Endocrinology 68: 68-79.
5. Baulieu, E.E. (1991). The antisteroid RU486. Its cellular and molecular mode of action. Trends Endocrin.Met. 2: 233-239.
6. Bogovich, K. (1989). Luteinizing hormone (LH)-like activity and follicle-stimulating hormone (FSH) are sufficient for the induction of cystic ovaries in hypophysectomized rats. In: Growth Factors and the Ovary, Edited by Hirshfield, A.N. Plenum, Newv York, NY.: 345-349.
7. Bogovich, K. (1991). Induction of ovarian follicular cysts in the pregnant rat by human chorionic gonadotropin. Biol.Reprod. 45: 34-42.
8. Brawer, J.R., Munoz, M., Farookhi, R. (1986). Development of the Polycystic Ovarian Condition (PCO) in the Estradiol Valerate-Treated Rat. Biol.Reprod. 35: 647-655.
9. Buyalos, R.P., Pekonen, F., Halme, J.K., Judd, H.L., Rutanen, E.M. (1995). The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome. Am.J.Obstet.Gynecol. 172: 932-939.
10. Campbell, C.S., Schwartz, N.B. (1980). The impact of constant light on the estrous cycle of the rat. Endocrinology 106: 1230-1238.
11. Carriere, P.D., Farookhi, R., Brawer, J.R. (1989). The role of aberrant hypothalamic opiatergic function in generating polycystic ovaries in the rat. Can.J.Physiol.Pharmacol. 67(8): 896-901.
12. Clayton, R.N., Ogden, V., Hodgkinson, J., Worswick, L., Rodin, D.A., Dyer, S., Meade, T.W. (1992). How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin.Endocrinol.(Oxf.) 37(2): 127-134.
13. Convery, M., McCarthy, G.F., Brawer, J.R. (1990). Remission of the polycystic ovarian condition (PCO) in the rat following hemiovariectiomy. Anat.Rec. 226(3): 328-336.
14. Conway, G.S. (1996). Polycystic ovary syndrome: clinical aspects. Baillieres Clin.Endocrinol. Metabol. 10: 263-279.
15. Conway, G.S., Honour, J.W., Jacobs, H.S. (1989). Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin.Endocrinol (Oxf), 30: 459-470.
16. Copmann, T.L., Adams, W.C. (1981). Relationship of polycystic ovary induction to prolactin secretion: prevention of cyst formation by bromocriptine in the rat. Endocrinology 108: 1095-1097.
17. Daane, T.A., Parlow, A.F. (1971). Serum FSH and LH in constant light-induced persistent estrus: short-term and long-term studies. Endocrinology 88: 964-68.
18. Duleba, A.J., Spaczynski, R.Z., Olive, D.L., Behrman, H.R. (1997). Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol.Reprod. 56(4): 891-897.
19. Dunaif, A. (1993). Insulin resistance in polycystic ovarian syndrome. In: Intraovarian Regulators and Polycystic Ovarian Syndrome. Edited by Tolis, G., Bringer, J., Chrousos, G.P. Recent Progress on Clinical and Therapeutic Aspects. New York: Annals of the New York Academy of Sciences vol. 687: 60-64.
20. Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L. (1995). Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr.Rev. 16: 322-353.
21. Farookhi, R., Hemmings, R., Brawer, J.R. (1985). Unilateral ovariectomy restores ovulatory cyclicyty in rats with a polycystic ovarian condition. Biol.Reprod. 32: 530-540.
22. Franks, S. (1989). Polycystic ovary syndrome: a changing perspective. Clin.Endocrinol. 31: 87-120.
23. Franks, S. White, M. (1993). Prevalence of and etiological factors in polycystic ovarian syndrome. In: Intraovarian Regulators and Polycystic Ovarian Syndrome Edited by Tolis, G., Bringer, J., Chrousos, G.P. Recent Progress on Clinical and Therapeutic Aspects. New York: Annals of the New York Academy of Sciences vol. 687: 112-114.
24. Goldzieher, J.W., Axelrod, L.R. (1963). Clinical and biochemical features of polycystic ovarian disease. Fertil.Steril. 14: 631-653.
25. Goldzieher, J.W., Green, J.A. (1962). The polycystic ovary. I. Clinical and histological features. J.Clin.Endocrinol.Metab. 22: 325-338.
26. Gougeon, A. (1996). Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrine Reviews 17: 121-156.
27. Hillier, S.G., Miró, F. (1993). Inhibin, Activin, and Follistatin: Potential Roles in Ovarian Physiology. In: Intraovarian Regulators and Polycystic Ovarian Syndrome Edited by Tolis, G., Bringer, J., Chrousos, G.P. Recent Progress on Clinical and Therapeutic Aspects. New York: Annals of the New York Academy of Sciences vol. 687: 29-38.
28. Hughesdon, P.E. (1982). Morphology and morphogenesis of the Stein-Leventhal ovary and the so-called "hyperthecosis".Obstet.Gynecol.Surv. 37: 59-77.
29. Jacobs, H.S. (1996). Polycystic ovary syndrome: the present position. Gynecol.Endocrinol. 10(6): 427-433.
30. Jones, H.M., Vernon, M.W., Rush, M.E. (1987). Systematic Studies Invalidate the Neonatally Androgenized Rat as a Model for Polycystic Ovary Disease. Biol.Reprod. 36: 1253-1265.
31. Knudsen, J.R., Costoff, A., Mahesh, V.B. (1975). Dehydroepiandrosterone induced polycystic ovaries and acyclicyty in the rat. Fertil.Steril. 26: 807-817.
32. Lee, M.T., Adams, W.C., Bruot, B.C. (1991). Circulating hormone concentrations in hypothyroid rats with induced polycystic ovaries. Proc.Soc.Exp.Biol.Med. 198(2): 737-741.
33. Lookingland, K.J., Wise, P.M., Barraclough, C.A. (1982). Failure of the hypothalamic noradrenergic system to function in adult androgen-sterilized rats. Biol.Reprod. 27: 268-281.
34. Mahajan, D.K. (1988). Polycystic ovarian disease: animal models. Endocrinol.Metab.Clin. North.Am. 17: 705-732.
35. Mahesh, V.B., Mills, T.M., Bagnell, C.A., Conway, B.A. (1987). Animal models for study of polycystic ovaries and ovarian atresia. In: Regulation of Ovarian and Testicular Function. Edited by Mahesh, V.B., Dhindssa, D.S., Anderson, E., Kalra, S.P., Plenum Press, New York:: 237-257.
36. McCarthy, G.F., Brawer, J.R. (1990). Induction of Stein-Leventhal-like polycystic ovaries (PCO) in the rat: a new model for cystic ovarian disease. Anat.Rec. 228(2): 137-144.
37. Nobels, F., Dewailly, D. (1992). Puberty and polycystic ovarian syndrome: the insulin/ insulin-like growth factor I hypothesis. Fertil.Steril. 58: 655-666.
38. Palumbo, A., Pourmotabbed, G., Carcangiu, M.L., Andrade-Gordon, P., Roa, L., DeCherney, A., Naftolin, F. (1993a). Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil.Steril. 60(2): 280-284.
39. Palumbo, A., Carcangiu, M.L., Roa, L., Pepperell, J., Pourmotabbed, G., Naftolin, F. (1993b). The Ovarian Renin-Angiotensin System in Polycystic Ovarian Syndrome. In: Intraovarian Regulators and Polycystic Ovarian Syndrome, Edited by Tolis, G., Bringer, J., Chrousos, G.P. Recent Progress on Clinical and Therapeutic Aspects. New York: Annals of the New York Academy of Sciences vol. 687: 39-45.
40. Parker, C.R., Mahesh, V.B. (1976). Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure. J.Reprod.Med. 17: 75-90.
41. Poretsky, L., Clemons, J., Bogovich, K. (1992). Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. Metabolism 41(8): 903-910.
42. Poretsky, L., Glover, B., Laumas, V., Kalin, M., Dunaif, A. (1988). The effects of experimental hyperinsulinemia on steroid secretion, ovarian 125-I-insulin binding and ovarian 125-I-Insulin-like growth factor I binding in the rat. Endocrinology 122: 581-585.
43. Rittmaster, R.S., Deshwal, N., Lehman, L. (1993). The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome. J.Clin. Endocrinol.Metab. 76: 1295-1300.
44. Ruiz, A., Aguilar, R., Tébar, M., Gaytán, F., Sánchez-Criado, J.E. (1996). RU486-Treated Rats Show Endocrine and Morphological Responses to Therapies Analogous to Responses of Women with Polycystic Ovary Syndrome Treated with Similar Therapies. Biol.Reprod. 55: 1284-1291.
45. Sánchez-Criado, J.E., Uilenbroek, J.Th.J., de Jong, F.H. (1992). Antiprogesterone RU486 increases serum immunoreactive inhibin levels and LH :FSH and testosterone :oestradiol ratios in cyclic rats., J.Endocrinol, 134: 51-57.
46. Schulster, A., Farookhi, R., Brawer, J.R. (1984). Polycystic ovarian condition in estradiol valerate-treated rats: spontaneous changes in characteristic endocrine features. Biol.Reprod. 31: 587-93.
47. Singh, K.B. (1969). Persistent estrus: an experimental model of the polycystic ovary syndrome. Obstet.Gynecol.Surv. 24: 2-17.
48. Smith, M.S., Freeman, M.E., Neil, J.D. (1975). The control of progesterone secretion during the estrous cycle and pseudopregnancy in the rat: Prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96: 219-226.
49. Stein, I.F., Levental, M.L. (1935). Amenorrhea associated with bilateral polycystic ovaries. Am.J.Obstet.Gynecol. 29: 181-191.
50. Uilenbroek, J.Th.J. (1991). Hormone concentrations and ovulatory response in rats treated with antiprogestagens. J.Endocrinol. 128: 423-429.
51. van der Schoot, P., Bakker, G.H., Klijn, J.G.M. (1987). Effect of the progesterone antagonist RU486 on ovarian activity in the rat Endocrinology 121: 1375-1382.
52. Ward, R.C., Costoff, A., Mahesh, V.B. (1987). The induction of polycystic ovaries in mature cyclic rats by the administration of dehydroepiandrosterone (DHA). Biol.Reprod. 18: 614-623.